Study on the difference of sunitinib and sorafenib as first-line treatment in advanced renal carcinoma

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DF9291CB.svg?ark=w1%2F20260515%2FDF9291CB)](https://nobleid.org/work/w1/20260515/DF9291CB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors